Lv5
950 积分 2020-04-16 加入
Asymmetric Synthesis of the cis-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation
5个月前
已完结
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
5个月前
已完结
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
6个月前
已完结
Recent progress in the structural biology of P2X receptors
11个月前
已完结
The discovery and development of gefapixant
11个月前
已完结
Gefapixant: First Approval
11个月前
已完结
Physicochemical Property Determinants of Oral Absorption for PROTAC Protein Degraders
1年前
已完结
皖公网安备34019202002308
